Education
About Us
Working with TipRanks
Follow Us
Charles Theuer Insider Profile
81 Followers
Charles Theuer, President & CEO, Director at TRACON Pharmaceuticals, holds 406.42K shares in TRACON Pharmaceuticals (Ticker: TCON), holds 14.68K shares in Oncternal Therapeutics (Ticker: ONCT), holds ― shares in 4D Molecular Therapeutics (Ticker: FDMT).
Charles Theuer TRACON Pharmaceuticals (TCON)President & CEO, Director
TRACON Pharmaceuticals (TCON)
President & CEO, Director
Ranked #940 out of 100,956 Corporate Insiders
Profitable Transactions
10 out of 33 Profitable Transactions
Average Return
+38.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Charles Theuer does not currently own shares as a corporate insider.
A breakdown of Charles Theuer's holdings
Insider Roles
Director
Roles that Charles Theuer holds in companies
Most Profitable Insider Trade
Stock:
TRACON Pharmaceuticals
(TCON)
(TCON)
Rating:Informative Buy
Date:Mar 13, 2020 - Mar 13, 2021
Return:+750.40%
The most profitable trade made by Charles Theuer
Charles Theuer's Trading History
TRACON Pharmaceuticals
Mar 13, 2024
―
Uninformative Buy
910.00
$13.01K
Oncternal Therapeutics
Jun 11, 2019
―
Uninformative Buy
―
$7.72K
4D Molecular Therapeutics
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Charles Theuer's performance on stock
You May Also Like
Charles Theuer insider profile FAQ
What is the percentage of profitable transactions made by Charles Theuer?
The percentage of profitable transactions made by Charles Theuer is 30%.
What is the average return per transaction made by Charles Theuer?
The average return per transaction made by Charles Theuer is 38.60%.
What stocks does Charles Theuer hold?
Charles Theuer holds: TCON, ONCT, FDMT stocks.
What was Charles Theuer’s latest transaction?
Charles Theuer latest transaction was an Uninformative Buy of $910.00.
What was Charles Theuer's most profitable transaction?
Charles Theuer’s most profitable transaction was an Informative Buy of TCON stock on March 13, 2020. The return on the trade was 750.40%.
What is Charles Theuer's role in TRACON Pharmaceuticals?
Charles Theuer's role in TRACON Pharmaceuticals is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.